← Leaderboards
Thu Ha Truong
University Of Minnesota
$751,817
Attributed
$751,817
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $201.7K · FY2017–25$250K$187.5K$125K$62.5K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$751,817 · 2
By mechanism
K22$605,232 · 1
F32$146,585 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Carol Ann Lange$17,870,830
- Carol Ann Sartorius$5,515,814
- Jian-Guo Geng$4,434,494
- Julie H Ostrander$1,836,395
- John E Wagner$7,593,142
Others in their field
Other Emerging Leaders on “Genetic Transcription”
- Evan Z Macosko · Broad Institute, Inc.$30,129,032
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Tomasz Nowakowski · University Of California, San Francisco$12,105,692
- Chun Jimmie Ye · Feinstein Institute For Medical Research$11,595,683
- Yin Shen · University Of California, San Francisco$10,418,368
- Chongyuan Luo · University Of California Los Angeles$9,805,856
Research focus
Genetic TranscriptionMolecularEstrogen Receptor PositiveGenetic SignatureKnock-DownMammary NeoplasmsComplexEndocrineFoundationsGenesHormone TherapyIn VivoLinkMalignant Breast NeoplasmBreast Cancer CellCareerBreast Cancer PatientCytoplasmEstrogen ReceptorsEventBindingCancer CellCell ModelNcoa3 Gene
Grant awards (6)
Targeting Oncogenic PELP1/SRC-3 Signaling Complexes in ER+ Breast Cancer$201,744
K22 · FY2025 · CA · contact PI
Targeting Oncogenic PELP1/SRC-3 Signaling Complexes in ER+ Breast Cancer$201,744
K22 · FY2024 · CA · contact PI
Targeting Oncogenic PELP1/SRC-3 Signaling Complexes in ER+ Breast Cancer$201,744
K22 · FY2023 · CA · contact PI
PELP1 mislocalization favors hormone-induced breast cancer development$24,385
F32 · FY2019 · CA · contact PI
PELP1 mislocalization favors hormone-induced breast cancer development$63,034
F32 · FY2018 · CA · contact PI
PELP1 mislocalization favors hormone-induced breast cancer development$59,166
F32 · FY2017 · CA · contact PI